![]() |
|
|
Vol. 58, Issue 4, 845-851, October 2000
Laboratory of Metabolism, National Cancer Institute, National
Institute of Health, Bethesda, Maryland (M.T., G.E., S.T., F.J.G.); and
Department of Pharmaceutical Sciences, National Institute of Public
Health, Minato-ku, Tokyo, Japan (M.T., M.F.)
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription
factor that mediates the biological responses to environmental contaminants such as
2,3,7,8-tetrachlorodibenzo-p-dioxin. Embryonic fibroblast (EF) isolated from AHR-null mice exhibited slow cell growth
compared with wild-type EF. Reintroduction of AHR into AHR-null EF
increased cell growth, suggesting that AHR is involved in cell cycle
control. The role of the AHR in cell cycle control was examined using
the adenovirus oncoprotein E1A. EF, derived from wild-type and AHR-null
mice, were transfected with two mutant E1A expression plasmids that
inactivate either p300/CBP or retinoblastoma protein (pRb). Although
DNA synthesis of wild-type EF was induced by both E1A mutants, DNA
synthesis in the AHR-null EF was induced only by the mutant that binds
pRb, not by the mutant to p300/CBP. These data show that both pRb and
p300/CBP were the target of E1A-induced DNA synthesis in wild-type EF.
In AHR-null mice, however, only pRb was the target of E1A-induced DNA
synthesis and p300/CBP cannot be inactivated by E1A in the absence of
AHR. Immunoprecipitation revealed that AHR directly bound to p300, thus
suggesting the intriguing possibility that AHR is involved in control
of the cell cycle via interaction with p300.
This article has been cited by other articles:
![]() |
L. H. Kasper, T. Fukuyama, M. A. Biesen, F. Boussouar, C. Tong, A. de Pauw, P. J. Murray, J. M. A. van Deursen, and P. K. Brindle Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development Mol. Cell. Biol., February 1, 2006; 26(3): 789 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mulero-Navarro, E. Pozo-Guisado, P. A. Perez-Mancera, A. Alvarez-Barrientos, I. Catalina-Fernandez, E. Hernandez-Nieto, J. Saenz-Santamaria, N. Martinez, J. M. Rojas, I. Sanchez-Garcia, et al. Immortalized Mouse Mammary Fibroblasts Lacking Dioxin Receptor Have Impaired Tumorigenicity in a Subcutaneous Mouse Xenograft Model J. Biol. Chem., August 5, 2005; 280(31): 28731 - 28741. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Huang and C. J. Elferink Multiple Mechanisms Are Involved in Ah Receptor-Mediated Cell Cycle Arrest Mol. Pharmacol., January 1, 2005; 67(1): 88 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Santiago-Josefat, S. Mulero-Navarro, S. L. Dallas, and P. M. Fernandez-Salguero Overexpression of latent transforming growth factor-{beta} binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts J. Cell Sci., February 22, 2004; 117(6): 849 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, J. A. Powell-Coffman, and Y. Jin The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans Development, February 15, 2004; 131(4): 819 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Levine-Fridman, L. Chen, and C. J. Elferink Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity Mol. Pharmacol., February 1, 2004; 65(2): 461 - 469. [Abstract] [Full Text] [PDF] |
||||